Aston Institute for Membrane Excellence (AIME) has been awarded a £500,000 grant from the Wolfson Foundation to acquire an ultrafast spinning disc confocal microscope, enhancing research into ...

The US Food and Drug Administration (FDA) has approved Alexion, AstraZeneca Rare Disease’s Ultomiris (ravulizumab-cwvz) to treat adults with anti-aquaporin-4 (AQP4) antibody-positive (Ab+ ...